Key result
New therapies for peripheral arterial disease are under development to minimize local disease progression, reduce systemic cardiovascular morbidity, and augment surgical interventions.
Population
Patients with peripheral arterial disease (PAD)
Design
Review
Authors
Loading...
Current PAD management extrapolates from coronary data; leaves open whether emerging limb-specific therapies will improve outcomes.
Current medical management of PAD relies heavily on extrapolation from coronary literature, highlighting the need for emerging therapies targeting limb-specific and systemic outcomes.
Tulsyan et al. (2006) conducted a review in Peripheral arterial disease (PAD). Emerging drugs was evaluated. New therapies for peripheral arterial disease are under development to minimize local disease progression, reduce systemic cardiovascular morbidity, and augment surgical interventions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: